BDi is an industrial biotech company offering end-to-end bioprocess development services, from strain improvement to industrial-scale fermentation, for pharmaceutical, veterinary and food markets. The company operates offices, laboratories and a fermentation plant in the Parque Tecnológico de Boecillo (Valladolid) in Castilla y León. BDi has sustained growth that has helped it position as a sector reference and is developing relationships with leading companies. The recently raised capital is intended to further support the company’s international expansion. Management emphasizes scientific excellence and market knowledge, and says a technically strong team has attracted strategic partners and investors. BDi is also positioned to collaborate on platform technologies such as Dyadic’s C1 expression system for lower‑cost biologics and vaccines.

Total raised

$5M

Funding rounds

2

Latest round

Equity

Latest activity

Jan 2018